GSRX Industries Inc.

OTC: GSRX · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Dorado, PRCIK 0001381240Reports USD

#614 of 1,394 Healthcare companies by revenuetop-decile growth

EA Score

——

FH —DQ 4GM —SS 32

v0.1 · 25/100 weight · pillars only

↑ revenue growth (YoY), listing tenure · ↓ filing timeliness, return on equity

Methodology →

Revenue TTM

$10.1M

Rev growth YoY (TTM)

-5.5%

Net income (FY)

-$36.3M

Employees

Market cap

$8.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$11.0M$11.0M2019

Net income-$36.3M-$36.3M2019

Operating income-$25.4M-$25.4M2019

Total assets$8.0M$8.0M2019

Liabilities$3.6M$3.6M2019

Equity$4.6M$4.6M2019

Revenue by segment

Filed disclosures · FY2019

By product

Retail100%

Wholesale0%

By geography

Puerto Rico94%

California5%

Texas1%

Tennessee0%

The read

GSRX Industries Inc. booked $11.0M in FY2019 revenue, growing 310% year over year — faster than 92% of Healthcare companies we track, at a -329.5% net margin.

Peers · Healthcare

HTC Purenergy Inc.——Accelera Innovations, Inc——Neurogenesis, Inc.——Upper Street Marketing Inc.——

Key facts

CEOTroy Nihart

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersDorado, PR

ExchangeOTC: GSRX

Employees4

IPO date2007-12-20

Latest filings

10-Q2021-02-16 10-Q2021-02-16 10-Q2021-02-16 8-K2021-01-08 8-K2020-11-24 8-K2020-10-22 10-K2020-06-11 8-K2020-05-15

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.